Bio-X Affiliated Faculty
Dr. Berek's research interests include drug development for ovarian cancer: he is currently studying levels of GBP1 expression, target protein levels, and the drug effect.
Research News
Less is more? Focused genetic testing recommended for breast and ovarian cancers
February 10, 2021 - Stanford Medicine Scope
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results,...